Drug developers signing up to partner with Atomwise for hit discovery and lead optimization said deal structures made it attractive to take the plunge on the AI company's emerging technology.
Last week, Atomwise Inc. announced three JVs with U.S.-based cancer companies and a collaboration with Chinese pharma Hansoh Pharmaceutical Group Co. Ltd. (HKEX:03692). In the last year, Atomwise has also announced
